ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 118 filers reported holding ANIKA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,309,441 | -69.4% | 338,671 | -57.4% | 0.00% | -100.0% |
| Q2 2023 | $20,651,736 | -21.8% | 794,909 | -13.6% | 0.00% | 0.0% |
| Q1 2023 | $26,416,311 | -50.9% | 919,788 | -49.4% | 0.00% | -50.0% |
| Q4 2022 | $53,804,926 | +145.9% | 1,817,734 | +97.7% | 0.00% | +100.0% |
| Q3 2022 | $21,884,000 | +12.9% | 919,490 | +5.9% | 0.00% | 0.0% |
| Q2 2022 | $19,380,000 | -17.0% | 868,285 | -6.6% | 0.00% | 0.0% |
| Q1 2022 | $23,340,000 | -18.4% | 929,498 | +16.4% | 0.00% | 0.0% |
| Q4 2021 | $28,613,000 | -17.1% | 798,568 | -1.6% | 0.00% | -50.0% |
| Q3 2021 | $34,532,000 | -11.2% | 811,374 | -9.7% | 0.00% | 0.0% |
| Q2 2021 | $38,892,000 | +1.3% | 898,395 | -4.6% | 0.00% | 0.0% |
| Q1 2021 | $38,398,000 | +3.4% | 941,353 | +14.7% | 0.00% | 0.0% |
| Q4 2020 | $37,147,000 | +34.9% | 820,746 | +5.5% | 0.00% | 0.0% |
| Q3 2020 | $27,540,000 | -21.1% | 778,193 | -15.9% | 0.00% | -33.3% |
| Q2 2020 | $34,919,000 | +40.0% | 925,484 | +7.2% | 0.00% | +50.0% |
| Q1 2020 | $24,951,000 | -44.1% | 863,045 | +0.3% | 0.00% | -33.3% |
| Q4 2019 | $44,617,000 | +8.3% | 860,507 | +14.7% | 0.00% | 0.0% |
| Q3 2019 | $41,192,000 | +29.1% | 750,445 | -4.5% | 0.00% | +50.0% |
| Q2 2019 | $31,907,000 | +44.6% | 785,495 | +7.7% | 0.00% | 0.0% |
| Q1 2019 | $22,063,000 | +30.2% | 729,605 | +44.7% | 0.00% | 0.0% |
| Q4 2018 | $16,942,000 | -37.7% | 504,087 | -21.8% | 0.00% | 0.0% |
| Q3 2018 | $27,200,000 | +74.0% | 644,790 | +32.0% | 0.00% | +100.0% |
| Q2 2018 | $15,632,000 | -22.1% | 488,562 | +21.1% | 0.00% | -50.0% |
| Q1 2018 | $20,059,000 | -1.8% | 403,379 | +6.5% | 0.00% | 0.0% |
| Q4 2017 | $20,428,000 | -3.3% | 378,926 | +4.0% | 0.00% | 0.0% |
| Q3 2017 | $21,127,000 | +15.6% | 364,327 | -1.6% | 0.00% | 0.0% |
| Q2 2017 | $18,276,000 | +20.5% | 370,433 | +6.1% | 0.00% | +100.0% |
| Q1 2017 | $15,171,000 | -2.2% | 349,292 | +10.3% | 0.00% | 0.0% |
| Q4 2016 | $15,507,000 | +5.6% | 316,791 | +3.2% | 0.00% | 0.0% |
| Q3 2016 | $14,686,000 | -6.7% | 306,874 | +4.6% | 0.00% | -50.0% |
| Q2 2016 | $15,747,000 | +22.0% | 293,471 | +1.6% | 0.00% | +100.0% |
| Q1 2016 | $12,912,000 | +16.5% | 288,716 | -0.6% | 0.00% | 0.0% |
| Q4 2015 | $11,088,000 | -14.2% | 290,591 | -7.4% | 0.00% | 0.0% |
| Q1 2015 | $12,919,000 | +7.3% | 313,823 | +6.2% | 0.00% | 0.0% |
| Q4 2014 | $12,044,000 | +12.4% | 295,623 | +1.2% | 0.00% | 0.0% |
| Q3 2014 | $10,711,000 | -17.4% | 292,157 | +4.3% | 0.00% | 0.0% |
| Q2 2014 | $12,974,000 | +17.2% | 280,061 | +4.0% | 0.00% | 0.0% |
| Q1 2014 | $11,069,000 | +7.9% | 269,326 | -32.4% | 0.00% | 0.0% |
| Q4 2013 | $10,258,000 | +123.5% | 398,612 | +108.1% | 0.00% | 0.0% |
| Q3 2013 | $4,589,000 | +50.5% | 191,572 | +6.8% | 0.00% | – |
| Q2 2013 | $3,049,000 | – | 179,331 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 44,875 | $2,031,000 | 2.14% |
| Parian Global Management LP | 102,705 | $4,648,000 | 1.16% |
| CAPITAL MANAGEMENT CORP /VA | 93,035 | $4,211,000 | 1.15% |
| Avidity Partners Management LP | 731,000 | $33,085,000 | 1.07% |
| Sio Capital Management, LLC | 65,382 | $2,959,000 | 0.61% |
| DIKER MANAGEMENT LLC | 21,835 | $988,000 | 0.50% |
| Archon Capital Management LLC | 48,925 | $2,214,000 | 0.38% |
| Caption Management, LLC | 362,800 | $16,420,000 | 0.37% |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,546,260 | $69,984,000 | 0.20% |
| Boston Trust Walden Corp | 378,167 | $17,116,000 | 0.18% |